Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Incyte INCY in the ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 19.5% year on year to $1.05 billion. Its non ...

WILMINGTON, Del., May 07, 2025--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 33,413 shares of the Company ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results tomorrow morning. Here’s what investors should know. Incyte beat analysts’ revenue expectations by 3% last ...

WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Incyte Corp. (INCY) on Tuesday reported first-quarter profit of $158.2 million. The Wilmington, Delaware-based company said it had profit of 80 ...

Incyte (INCY) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.64 per share a year ago. These figures ...

The Rangers are doing this for the third time over the past five springs. Every other year, there is a coaching search. Every other year, there is an introductory news conference for the man of ...

April 29, 2025--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today reports 2025 first quarter financial results, and provides a status update on the Company’s clinical development portfolio.